Ahead of an FDA Decision on Its Pegfilgrastim Biosimilar, Sandoz Sues Amgen The Center for Biosimilars
This month, biosimilar developer Sandoz filed suit against Amgen, asking the United States district court for the Northern District of California for a declaratory …